BWAM
BLUE

Boyd Watterson Asset Management’s bluebird bio BLUE Stock Holding History

Boyd Watterson Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6
Closed -$171 – 442
2023
Q4 		$171 Hold
6
– – ﹤0.01% 419
2023
Q3 		$377 Hold
6
– – ﹤0.01% 408
2023
Q2 		$408 Hold
6
– – ﹤0.01% 409
2023
Q1 		$394 Hold
6
– – ﹤0.01% 410
2022
Q4 		$858 Buy
+6
New +$845 ﹤0.01% 398
2021
Q1 		– Sell
-818
Closed -$459K – 144
2020
Q4 		$459K Buy
+818
New +$518K 0.22% 103

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Boyd Watterson Asset Management's BLUE Position: Q1 2024 in Review

Boyd Watterson Asset Management sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 6 shares — an estimated $171 sold.

Boyd Watterson Asset Management first reported a position in BLUE in Q4 2020 and held it in 6 quarters. The position peaked at $459K in Q4 2020. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

  • Boyd Watterson Asset Management reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
  • Boyd Watterson Asset Management sold 6 bluebird bio shares in Q1 2024, an estimated $171.
  • Boyd Watterson Asset Management first reported a position in bluebird bio in Q4 2020 and held it in 6 quarters.
  • Boyd Watterson Asset Management's bluebird bio position peaked at $459K in Q4 2020.
  • 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on Boyd Watterson Asset Management's 13F filing for Q1 2024, filed 29 Apr 2024.